KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Receivables (2017 - 2025)

Guardant Health (GH) has disclosed Change in Receivables for 9 consecutive years, with $22.2 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables rose 2.3% to $22.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.2 million through Dec 2025, up 31.73% year-over-year, with the annual reading at $28.2 million for FY2025, 31.73% up from the prior year.
  • Change in Receivables hit $22.2 million in Q4 2025 for Guardant Health, up from -$14.5 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $36.9 million in Q4 2021 to a low of -$14.5 million in Q3 2025.
  • Historically, Change in Receivables has averaged $4.3 million across 5 years, with a median of $4.0 million in 2021.
  • Biggest five-year swings in Change in Receivables: tumbled 3038.55% in 2021 and later soared 120683.33% in 2024.
  • Year by year, Change in Receivables stood at $36.9 million in 2021, then plummeted by 70.04% to $11.1 million in 2022, then plummeted by 100.16% to -$18000.0 in 2023, then skyrocketed by 120683.33% to $21.7 million in 2024, then rose by 2.3% to $22.2 million in 2025.
  • Business Quant data shows Change in Receivables for GH at $22.2 million in Q4 2025, -$14.5 million in Q3 2025, and $14.3 million in Q2 2025.